Are we sold yet?

[Anonymous]

Any news on this front? The CEO does not say much. IPO? Sales through the roof? Many new products in 2012?

 

[Anonymous]

They will sell the product lines; they plan on terminating us all in the end.

 

[Anonymous]

inside here. Think the new drug company that just received 2 new glaucoma approvals. Can't say more, but make sure you have resume updated

 

[Anonymous]

inside here. Think the new drug company that just received 2 new glaucoma approvals. Can't say more, but make sure you have resume updated

FDA Approves Zioptan (tafluprost ophthalmic solution), Merck's Once-Daily, Preservative-Free Ophthalmic Medication- Feb 13 2012

Taflotan® (Tafluprost, Merck, Santen) for glaucoma and ocular hypertension.

10 November 2011

Taflotan approved and marketed in Europe.

 

[Anonymous]

Merck is not buying us